{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:40:22Z","timestamp":1790689222201,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":437,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["U54TR001356"],"award-info":[{"award-number":["U54TR001356"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AR063381"],"award-info":[{"award-number":["UM1 AR063381"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008893","name":"University of Iowa","doi-asserted-by":"publisher","award":["UL1TR000445"],"award-info":[{"award-number":["UL1TR000445"]}],"id":[{"id":"10.13039\/100008893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jpain.2022.02.008","type":"journal-article","created":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T18:47:19Z","timestamp":1647110839000},"page":"1268-1281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Influence of Opioids on Transcutaneous Electrical Nerve Stimulation Effects in Women With Fibromyalgia"],"prefix":"10.1016","volume":"23","author":[{"given":"Dana L.","family":"Dailey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3002-054X","authenticated-orcid":false,"given":"Carol G.T.","family":"Vance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Chimenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Rakel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam Bridget","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Sluka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie J.","family":"Crofford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2022.02.008_bib0001","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.mayocp.2012.02.010","article-title":"FibroCollaborative. A framework for fibromyalgia management for primary care providers","volume":"87","author":"Arnold","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jpain.2022.02.008_bib0002","first-page":"237","article-title":"Efficacy of duloxetine in patients with fibromyalgia: Pooled analysis of 4 placebo-controlled clinical trials","volume":"11","author":"Arnold","year":"2009","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.jpain.2022.02.008_bib0003","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jpain.2008.03.013","article-title":"A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia","volume":"9","author":"Arnold","year":"2008","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0004","first-page":"639","article-title":"Comparison of self-reported fatigue in rheumatoid arthritis and controls","volume":"22","author":"Belza","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpain.2022.02.008_bib0005","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/ar2783","article-title":"The Revised Fibromyalgia Impact Questionnaire (FIQR): Validation and psychometric properties","volume":"11","author":"Bennett","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jpain.2022.02.008_bib0006","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9343(03)00116-5","article-title":"Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: A double-blind, randomized, placebo-controlled study","volume":"114","author":"Bennett","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.jpain.2022.02.008_bib0007","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/art.21319","article-title":"Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol\/acetaminophen","volume":"53","author":"Bennett","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpain.2022.02.008_bib0008","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.jpain.2022.02.008_bib0009","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","article-title":"Validating the SF-36 health survey questionnaire: New outcome measure for primary care","volume":"305","author":"Brazier","year":"1992","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.jpain.2022.02.008_bib0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/RHU.0000000000001273","article-title":"Opioid use in fibromyalgia continues despite guidelines that do not support its efficacy or risk","volume":"27","author":"Bruce","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jpain.2022.02.008_bib0011","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jpain.2005.01.355","article-title":"Fear of movement: Factor structure of the tampa scale of kinesiophobia in patients with fibromyalgia syndrome","volume":"6","author":"Burwinkle","year":"2005","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0012","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jpain.2022.02.008_bib0013","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/s0304-3959(02)00381-0","article-title":"Development of opioid tolerance with repeated transcutaneous electrical nerve stimulation administration","volume":"102","author":"Chandran","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0014","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.jpain.2022.02.008_bib0015","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1097\/j.pain.0000000000001600","article-title":"Opioid use, pain intensity, age, and sleep architecture in patients with fibromyalgia and insomnia","volume":"160","author":"Curtis","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0016","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.pain.2013.07.043","article-title":"Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia","volume":"154","author":"Dailey","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0017","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/art.41170","article-title":"Transcutaneous electrical nerve stimulation reduces movement-evoked pain and fatigue: A randomized, controlled trial","volume":"72","author":"Dailey","year":"2020","journal-title":"Arthritis Rheumatol (Hoboken, N.J.)"},{"key":"10.1016\/j.jpain.2022.02.008_bib0018","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.apmr.2007.11.027","article-title":"Modulation between high- and low-frequency transcutaneous electric nerve stimulation delays the development of analgesic tolerance in arthritic rats","volume":"89","author":"DeSantana","year":"2008","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jpain.2022.02.008_bib0019","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2013United States","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2022.02.008_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pmn.2003.11.002","article-title":"The cognitive effects of opioids","volume":"5","author":"Ersek","year":"2004","journal-title":"Pain Manag Nurs"},{"key":"10.1016\/j.jpain.2022.02.008_bib0021","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/898493","article-title":"Opioid use in fibromyalgia is associated with negative health related measures in a prospective cohort study","author":"Fitzcharles","year":"2013","journal-title":"Pain Res Treat"},{"key":"10.1016\/j.jpain.2022.02.008_bib0022","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.amjmed.2011.05.031","article-title":"Opioid use, misuse, and abuse in patients labeled as fibromyalgia","volume":"124","author":"Fitzcharles","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jpain.2022.02.008_bib0023","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3899\/jrheum.130127","article-title":"Canadian Pain Society and Canadian Rheumatology Association recommendations for rational care of persons with fibromyalgia: A summary report","volume":"40","author":"Fitzcharles","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpain.2022.02.008_bib0024","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.mayocp.2016.02.002","article-title":"Opioid use in fibromyalgia: A cautionary tale","volume":"91","author":"Goldenberg","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jpain.2022.02.008_bib0025","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1526-4637.2009.00755.x","article-title":"Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study","volume":"11","author":"Goldenberg","year":"2010","journal-title":"Pain Med"},{"key":"10.1016\/j.jpain.2022.02.008_bib0026","doi-asserted-by":"crossref","first-page":"10000","DOI":"10.1523\/JNEUROSCI.2849-07.2007","article-title":"Decreased central mu-opioid receptor availability in fibromyalgia","volume":"27","author":"Harris","year":"2007","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.jpain.2022.02.008_bib0027","article-title":"Guidelines on the management of fibromyalgia syndrome - a systematic review","volume":"14","author":"Hauser","year":"2010","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0028","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1249\/MSS.0000000000000289","article-title":"Age group comparability of raw accelerometer output from wrist- and hip-worn monitors","volume":"46","author":"Hildebrand","year":"2014","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.jpain.2022.02.008_bib0029","doi-asserted-by":"crossref","first-page":"e13913","DOI":"10.1097\/MD.0000000000013913","article-title":"Association between initial opioid use and response to a brief interdisciplinary treatment program in fibromyalgia","volume":"98","author":"Hwang","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.jpain.2022.02.008_bib0030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0022-3565(24)29376-9","article-title":"Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS)","volume":"298","author":"Kalra","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpain.2022.02.008_bib0031","doi-asserted-by":"crossref","first-page":"145","DOI":"10.36076\/ppj.2011\/14\/145","article-title":"A comprehensive review of opioid-induced hyperalgesia","volume":"14","author":"Lee","year":"2011","journal-title":"Pain Physician"},{"key":"10.1016\/j.jpain.2022.02.008_bib0032","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jpain.2010.07.003","article-title":"Reduced analgesic effect of acupuncture-like TENS but not conventional TENS in opioid-treated patients","volume":"12","author":"L\u00e9onard","year":"2011","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0033","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.pain.2010.10.040","article-title":"An investigation of the development of analgesic tolerance to transcutaneous electrical nerve stimulation (TENS) in humans","volume":"152","author":"Liebano","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0034","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2217\/pmt-2016-0012","article-title":"Is there a role for opioids in the treatment of fibromyalgia?","volume":"6","author":"Littlejohn","year":"2016","journal-title":"Pain Manag"},{"key":"10.1016\/j.jpain.2022.02.008_bib0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s002210000629","article-title":"Reduction in inflammation-induced sensitization of dorsal horn neurons by transcutaneous electrical nerve stimulation in anesthetized rats","volume":"137","author":"Ma","year":"2001","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.jpain.2022.02.008_bib0036","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jpain.2022.02.008_bib0037","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3899\/jrheum.080734","article-title":"The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Mease","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpain.2022.02.008_bib0038","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13075-018-1671-3","article-title":"Physical activity is related to function and fatigue but not pain in women with fibromyalgia: Baseline analyses from the Fibromyalgia Activity Study with TENS (FAST)","volume":"20","author":"Merriwether","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jpain.2022.02.008_bib0039","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1756-185X.2010.01567.x","article-title":"The use of opioids in fibromyalgia","volume":"14","author":"Ngian","year":"2011","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jpain.2022.02.008_bib0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2522\/ptj.20140218","article-title":"Effect of transcutaneous electrical nerve stimulation on pain, function, and quality of life in fibromyalgia: A double-blind randomized clinical trial","volume":"95","author":"Noehren","year":"2015","journal-title":"Phys Ther"},{"key":"10.1016\/j.jpain.2022.02.008_bib0041","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/apmr.2002.27397","article-title":"Physical performance tasks: What are the underlying constructs?","volume":"83","author":"Novy","year":"2002","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jpain.2022.02.008_bib0042","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1023\/A:1005548801037","article-title":"The pain catastrophizing scale: Further psychometric evaluation with adult samples","volume":"23","author":"Osman","year":"2000","journal-title":"J Behav Med"},{"key":"10.1016\/j.jpain.2022.02.008_bib0043","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/RHU.0b013e3182863447","article-title":"Chronic opioid use in fibromyalgia syndrome: A clinical review","volume":"19","author":"Painter","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jpain.2022.02.008_bib0044","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clinthera.2013.02.003","article-title":"Geographic variation of chronic opioid use in fibromyalgia","volume":"35","author":"Painter","year":"2013","journal-title":"Clin Therap"},{"key":"10.1016\/j.jpain.2022.02.008_bib0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/AJP.0000000000000079","article-title":"Long-term evaluation of opioid treatment in fibromyalgia","volume":"31","author":"Peng","year":"2015","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0046","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3959(03)00207-0","article-title":"Blockade of spinal 5-HT receptor subtypes prevents low, but not high, frequency TENS-induced antihyperalgesia in rats","volume":"105","author":"Radhakrishnan","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0047","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jpain.2009.07.007","article-title":"A New Transient Sham TENS Device Allows for Investigator Blinding While Delivering a True Placebo Treatment","volume":"11","author":"Rakel","year":"2010","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0048","first-page":"72","article-title":"Patterns of pharmacologic and non-pharmacologic treatment, treatment satisfaction and perceived tolerability in patients with fibromyalgia: A patients' survey","author":"Rico-Villademoros","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jpain.2022.02.008_bib0049","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ejpain.2003.11.016","article-title":"The Tampa Scale for Kinesiophobia: Further examination of psychometric properties in patients with chronic low back pain and fibromyalgia","volume":"8","author":"Roelofs","year":"2004","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0050","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.pain.2008.02.024","article-title":"Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial","volume":"136","author":"Russell","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0051","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5055\/jom.2019.0537","article-title":"Opioid prescription patterns among patients with fibromyalgia","volume":"15","author":"Sarmento","year":"2019","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.jpain.2022.02.008_bib0052","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/j.pain.0000000000000633","article-title":"Endogenous opioidergic dysregulation of pain in fibromyalgia: A PET and fMRI study","volume":"157","author":"Schrepf","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0053","doi-asserted-by":"crossref","first-page":"679","DOI":"10.36076\/ppj.2009\/12\/679","article-title":"Opioid induced hyperalgesia: Clinical implications for the pain practitioner","volume":"12","author":"Silverman","year":"2009","journal-title":"Pain Physician"},{"key":"10.1016\/j.jpain.2022.02.008_bib0054","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1097\/00007632-199811150-00011","article-title":"Psychometric characteristics and clinical usefulness of physical performance tests in patients with low back pain","volume":"23","author":"Simmonds","year":"1998","journal-title":"Spine (Phila Pa.1976)"},{"key":"10.1016\/j.jpain.2022.02.008_bib0055","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0022-3565(24)38209-6","article-title":"Spinal blockade of opioid receptors prevents the analgesia produced by TENS in arthritic rats","volume":"289","author":"Sluka","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpain.2022.02.008_bib0056","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/eujp.2000.0172","article-title":"Low frequency TENS is less effective than high frequency TENS at reducing inflammation-induced hyperalgesia in morphine-tolerant rats","volume":"4","author":"Sluka","year":"2000","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0057","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00482-017-0207-0","article-title":"[Drug therapy of fibromyalgia syndrome: Updated guidelines 2017 and overview of systematic review articles]","volume":"31","author":"Sommer","year":"2017","journal-title":"Schmerz"},{"issue":"1","key":"10.1016\/j.jpain.2022.02.008_bib0058","doi-asserted-by":"crossref","DOI":"10.2165\/11530950-000000000-00000","article-title":"Pharmacological treatment of fibromyalgia syndrome: New developments","volume":"70","author":"Staud","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.jpain.2022.02.008_bib0059","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/ptj\/82.2.128","article-title":"Age- and gender-related test performance in community-dwelling elderly people: Six-minute walk test, berg balance scale, timed up & go test, and gait speeds","volume":"82","author":"Steffen","year":"2002","journal-title":"Phys Ther"},{"key":"10.1016\/j.jpain.2022.02.008_bib0060","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","article-title":"The pain catastrophizing scale: Development and validation","volume":"7","author":"MaB","year":"1995","journal-title":"Psychol Assess"},{"key":"10.1016\/j.jpain.2022.02.008_bib0061","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpain.2003.12.005","article-title":"Validation of the Brief Pain Inventory for chronic nonmalignant pain","volume":"5","author":"Tan","year":"2004","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0062","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jpain.2016.12.006","article-title":"Evidenced-based guidelines on the treatment of fibromyalgia patients: Are they consistent and if not, why not? Have effective psychological treatments been overlooked?","volume":"18","author":"Thieme","year":"2017","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0063","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.36076\/ppj.2008\/11\/S181","article-title":"Effectiveness of opioids in the treatment of chronic non-cancer pain","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.jpain.2022.02.008_bib0064","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2217\/pmt.14.13","article-title":"Using TENS for pain control: The state of the evidence","volume":"4","author":"Vance","year":"2014","journal-title":"Pain Manag"},{"key":"10.1016\/j.jpain.2022.02.008_bib0065","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1097\/j.pain.0000000000002144","article-title":"Reduction in movement-evoked paina dn fatigue during an initial 30-minute TENS treatment predicts TENS responders in women with fibromyalgia","volume":"162","author":"Vance","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0066","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0889-857X(21)00895-4","article-title":"Fibromyalgia","volume":"16","author":"Wolfe","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jpain.2022.02.008_bib0067","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res(Hoboken)"},{"key":"10.1016\/j.jpain.2022.02.008_bib0068","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/j.1532-2149.2012.00234.x","article-title":"Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia","volume":"17","author":"Wolfe","year":"2013","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpain.2022.02.008_bib0069","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1111\/pme.12914","article-title":"Opioid Induced Hyperalgesia","author":"Yi","year":"2015","journal-title":"Pain Med"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590022000463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590022000463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:52:09Z","timestamp":1778521929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590022000463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":69,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1526590022000463"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2022.02.008","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Influence of Opioids on Transcutaneous Electrical Nerve Stimulation Effects in Women With Fibromyalgia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2022.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Published by Elsevier Inc. on behalf of United States Association for the Study of Pain, Inc.","name":"copyright","label":"Copyright"}]}}